Cleared Traditional

K083687 - BAIXIN INTRAVASCULAR ADMINISTRATION SET

K083687 is an FDA 510(k) clearance for BAIXIN INTRAVASCULAR ADMINISTRATION SET, manufactured by Anhui Kangda Medical Products Co., Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 181-day FDA review.

K083687 · Anhui Kangda Medical Products Co., Ltd. · General Hospital
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2009
Decision
181d
Days
Class 2
Risk

K083687 is an FDA 510(k) clearance for the BAIXIN INTRAVASCULAR ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Anhui Kangda Medical Products Co., Ltd. (Pudong, Shanghai, CN). The FDA issued a Cleared decision on June 11, 2009 after a review of 181 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K083687

510(k) Number K083687 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 2008
Decision Date June 11, 2009
Days to Decision 181 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 129d · This submission: 181d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 1017
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K083687.
EXTENSION SET (STANDARDBORE TUBING), EXTENSION SET (MINIBORE TUBING), IV ADMINISTRATION SET ( STANDARD
K093271 · Victus, Inc. · Jan 2010
EXEL I.V. EXTENSION SET
K092172 · Exelint Intl. Co. · Jan 2010
DISPOSABLE TPE INFUSION SET
K090459 · Shan Dong Wei Gao Group Medical Polymer Products · Oct 2009
DISPOSABLE INFUSION SET
K090012 · Shan Dong Wei Gao Group Medical Polymer Products · Jun 2009
A6 LUER ACCESS DEVICE
K083723 · B.Braun Medical, Inc. · Jun 2009
MPS ACACIA POWER INJECTABLE INFUSION SET
K090809 · Mps Acacia · Apr 2009
K083687 · BAIXIN INTRAVASCULAR ADMINISTRATION SET
Download PDF FDA Summary Anhui Kangda Medical …